PALISADE BIO INC (PALI) Stock Analyst Earnings Estimates
NASDAQ:PALI - Nasdaq - US6963894026 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 250K | -100.00% | 69.752M | 112.39M 61.13% | 227.96M 102.83% | |||||||
| EBITDA YoY % growth | -11.735M -10.88% | -15.308M -30.45% | -12.841M 16.12% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.737M -9.94% | -15.311M -30.45% | -12.845M 16.11% | -16.113M -25.44% | -21.535M -33.65% | -26.202M -21.67% | -42.637M -62.72% | -72.283M -69.53% | -66.055M 8.62% | 31.744M 148.06% | 14.274M -55.03% | 44.961M 214.99% | |
| Operating Margin | N/A | N/A | -5,138.00% | N/A | N/A | N/A | N/A | N/A | N/A | 45.51% | 12.70% | 19.72% | |
| EPS YoY % growth | N/A | -247.95 91.73% | -29.10 88.26% | -12.60 56.71% | -3.89 69.14% | -3.79 2.40% | -4.36 -14.78% | -5.96 -36.89% | -3.81 36.01% | -0.29 92.38% | 3.97 1,464.91% | 12.46 214.14% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -2.20 65.84% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -4.335M -31.72% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -2.32 64.85% | -3.42 | 1.10 | 32.15% |
| Q2 2024 Q2Q % growth | -3.32 58.24% | -2.99 | -0.33 | -11.13% |
| Q1 2024 Q2Q % growth | -4.59 43.33% | -4.90 | 0.31 | 6.25% |
| Q4 2023 Q2Q % growth | -6.45 -106.65% | -5.28 | -1.17 | -22.19% |
| Q3 2023 Q2Q % growth | -6.60 89.00% | -6.03 | -0.57 | -9.49% |
| Q2 2023 Q2Q % growth | -7.95 91.17% | -6.93 | -1.02 | -14.70% |
| Q1 2023 Q2Q % growth | -8.10 95.85% | -11.06 | 2.96 | 26.78% |
| Q4 2022 Q2Q % growth | 97.05 61.75% | -37.26 | 134.31 | 360.50% |
| Q3 2022 Q2Q % growth | -60.00 -119.05% | -61.20 | 1.20 | 1.96% |
| Q2 2022 Q2Q % growth | -90.00 -11,900.00% | -175.95 | 85.95 | 48.85% |
| Q1 2022 Q2Q % growth | -195.00 | -214.20 | 19.20 | 8.96% |
| Q4 2021 Q2Q % growth | 60.00 | -179.78 | 239.78 | 133.38% |
| Q3 2021 Q2Q % growth | 315.00 | -275.40 | 590.40 | 214.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | 2.5K | % | ||
| Q3 2020 Q2Q % growth | 2.5K | % | ||
| Q2 2020 Q2Q % growth | 2.5K -68.35% | % | ||
| Q1 2020 Q2Q % growth | 6K 140.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2600% | 0% | -1.4% |
| Revenue | N/A | N/A | N/A | N/A |